Probenecid, an organic anion transporter 1 and 3 inhibitor, increases plasma and brain exposure of N-acetylcysteine.
about
NIH workshop report on the trans-agency blood-brain interface workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface.Phase I randomized clinical trial of N-acetylcysteine in combination with an adjuvant probenecid for treatment of severe traumatic brain injury in children.Nitro-fatty acid inhibition of triple negative breast cancer cell viability, migration, invasion and tumor growth.Combination Therapy for Multi-Target Manipulation of Secondary Brain Injury Mechanisms.The pharmacogenomics of severe traumatic brain injury.
P2860
Probenecid, an organic anion transporter 1 and 3 inhibitor, increases plasma and brain exposure of N-acetylcysteine.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Probenecid, an organic anion t ...... exposure of N-acetylcysteine.
@en
Probenecid, an organic anion t ...... exposure of N-acetylcysteine.
@nl
type
label
Probenecid, an organic anion t ...... exposure of N-acetylcysteine.
@en
Probenecid, an organic anion t ...... exposure of N-acetylcysteine.
@nl
prefLabel
Probenecid, an organic anion t ...... exposure of N-acetylcysteine.
@en
Probenecid, an organic anion t ...... exposure of N-acetylcysteine.
@nl
P2093
P2860
P1433
P1476
Probenecid, an organic anion t ...... exposure of N-acetylcysteine.
@en
P2093
Fanuel T Hagos
Jacob A Ocque
Monica J Daood
Patrick M Kochanek
Philip E Empey
Robert S B Clark
Samuel M Poloyac
Thomas D Nolin
P2860
P304
P356
10.1080/00498254.2016.1187777
P407
P50
P577
2016-06-09T00:00:00Z